Democratic Republic of the Congo

Last Updated 25 May 2022.

4 Vaccines Approved for Use in Democratic Republic of the Congo

• Moderna
  Spikevax

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 86 countries

  63 trials in 22 countries

  Approval Source: actualite.cd

  RNA

• Pfizer/BioNTech
  Comirnaty

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 146 countries

  80 trials in 26 countries

  Approval Source: actualite.cd

  RNA

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 111 countries

  23 trials in 23 countries

  Approval Source: actualite.cd

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  Vaxzevria

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 140 countries

  63 trials in 30 countries

  Approval Source: aa.com.tr

  Non Replicating Viral Vector

2 Vaccines in Clinical Trials in Democratic Republic of the Congo

• Novavax
  Nuvaxovid

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 37 countries

  16 trials in 12 countries

  Protein Subunit

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 111 countries

  23 trials in 23 countries

  Non Replicating Viral Vector